Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00559936 · ClinicalTrials.gov registry record · Phase 1
Topical Avastin for Treatment of Corneal Neovascularization
A Phase 1 study, sponsored by Massachusetts Eye and Ear Infirmary.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT00559936 is a Phase 1 study that has completed, run by Massachusetts Eye and Ear Infirmary. The registered enrollment target is 24 participants.
The verdict
NCT00559936, a Phase 1 study, has completed, sponsored by Massachusetts Eye and Ear Infirmary.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness and safety of Topical Bevacizumab (Avastin) for treatment of corneal neovascularization.
Interventions
- DRUG Topical Avastin 1%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00559936
The ClinicalTrials.gov registry entry for NCT00559936 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Eye and Ear Infirmary, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topical Avastin 1% is the first listed.
NCT00559936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00559936 about?
NCT00559936 is a clinical study titled "Topical Avastin for Treatment of Corneal Neovascularization". The purpose of this study is to determine the effectiveness and safety of Topical Bevacizumab (Avastin) for treatment of corneal neovascularization.
What is the current status of trial NCT00559936?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2007-02. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00559936?
The interventions under investigation include: Topical Avastin 1% (DRUG).
Who is sponsoring clinical trial NCT00559936?
This trial is sponsored by Massachusetts Eye and Ear Infirmary, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.